Related references
Note: Only part of the references are listed.Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination
Kristin G. I. Mohn et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
ViroSpot microneutralization assay for antigenic characterization of human influenza viruses
Carel A. van Baalen et al.
VACCINE (2017)
Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model
Irina Isakova-Sivak et al.
VIROLOGY (2017)
Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
Andrey Rekstin et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?
Irina Isakova-Sivak et al.
EXPERT REVIEW OF VACCINES (2016)
Molecular basis for universal HLA-A☆0201-restricted CD8+ T-cell immunity against influenza viruses
Sophie A. Valkenburg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial
W. Abdullah Brooks et al.
LANCET GLOBAL HEALTH (2016)
Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages
Heather M. Machkovech et al.
JOURNAL OF VIROLOGY (2015)
The immune epitope database (IEDB) 3.0
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2015)
Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities
Sergio Quinones-Parra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Acute emergence and reversion of influenza A virus quasispecies within CD8+ Tcell antigenic peptides
Sophie A. Valkenburg et al.
NATURE COMMUNICATIONS (2013)
Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
Daniel F. Hoft et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2)
Irina Isakova-Sivak et al.
VIROLOGY (2011)
Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus
Jeff Alexander et al.
HUMAN IMMUNOLOGY (2010)
The comparative genomics of viral emergence
Edward C. Holmes
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cross- reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses
Stephanie Gras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Influenza virus CTL epitopes, remarkably conserved and remarkably variable
Guus F. Rimmelzwaan et al.
VACCINE (2009)
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age
Stan L. Block et al.
VACCINE (2008)
Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development
Guus F. Rimmelzwaan et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening
Mingjun Wang et al.
VACCINE (2007)
The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage
M Nielsen et al.
IMMUNOGENETICS (2005)
Mapping the antigenic and genetic evolution of influenza virus
DJ Smith et al.
SCIENCE (2004)
Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site
NJ Beekman et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
